Inventor · disambiguated record
Trevor Smith
Also filed as: SMITH TREVOR · SMITH TREVOR R F · SMITH TREVOR RF
2 granted patents·9 pending applications·2 citations·filing 2017–2024
43Inventor score
Top patents by PatentIndex Score
11 records- 0181US11230592B2DNA antibody constructs for use against middle east respiratory syndrome coronavirusWISTAR INST·Filed 2018·Granted Jan 25, 2022·2 cites·8 claims
- 0276US2024376179A1Dna antibody constructs for use against middle east respiratory syndrome coronavirusWISTAR INST·Filed 2024·Application pending·0 cites
- 0372US11981724B2DNA antibody constructs for use against middle east respiratory syndrome coronavirusWISTAR INST·Filed 2021·Granted May 14, 2024·0 cites·14 claims
- 0464US2024409619A1Antibodies for use against sars-cov-2WEINER DAVID·Filed 2022·Application pending·0 cites
- 0564US2024409618A1DNA ENCODED ANTIBODIES WITH Fc MODIFICATIONSWEINER DAVID·Filed 2022·Application pending·0 cites
- 0663US2023340033A1Immunogenic Compositions Against SARS-COV-2 Variants And Their Methods Of UseINOVIO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0762US2023092556A1In vivo use of chondroitinase and/or hyaluronidase to enhance delivery of an agentINOVIO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0855US2022339280A1Immunogenic Compositions Against SARS-COV-2 Variants and Their Methods of UseINOVIO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0950US2022331421A1Methods of Inducing Immune Response Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of ConcernINOVIO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1046US2021047390A1Nucleic acid antibody constructs for use against respiratory syncytial virusWISTAR INST·Filed 2019·Application pending·0 cites
- 1144US2019284263A1In vivo use of chondroitinase and/or hyaluronidase to enhance delivery of an agentINOVIO PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Trevor Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →